Ascilion (Sweden)
Sampling of dermal Interstitial Fluid (dISF) – Pioneering Hollow Microneedles – Ascilion designs, develops, and manufactures products based on hollow microneedles for sampling of dermal interstitial fluid (dISF). Access to endogenous and exogeneous biomolecules in dISF represents a unique opportunity for analysis of vital markers, health conditions and research. Bringing biomolecules out of the body and into analysis is paramount for the next step within life science.
Basic Information
- Category: business
- Founded: 2019
- Website: http://ascilion.com/
Documented Facts
- Email: info@ascilion.com (No linked source recorded for this statement.)
- Founded: 2019 (No linked source recorded for this statement.)
Evidence and Sources
- Ascilion (Sweden) — Official Site (official)
Citation Guidance
Explore business profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Ascilion (Sweden).
- Canonical profile: https://brandsource.ai/brands/ascilion-sweden
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/ascilion-sweden/json-ld
- Citation profile API: https://brandsource.ai/api/brands/ascilion-sweden/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (80/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2026-04-22
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
Sampling of dermal Interstitial Fluid (dISF) – Pioneering Hollow Microneedles – Ascilion designs, develops, and manufactures products based on hollow microneedles for sampling of dermal interstitial fluid (dISF). Access to endogenous and exogeneous biomolecules in dISF represents a unique opportunity for analysis of vital markers, health conditions and research. Bringing biomolecules out of the body and into analysis is paramount for the next step within life science.
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 2 structured facts available for extraction.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.